Portage Biotech Inc PRTG

Healthcare Biotechnology

Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is advancing therapies to improve long-term treatment response and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of six diverse platforms, with programs including invariant natural killer T cell (iNKT) agonists, which includes PORT-2 and PORT-3, therapies that activate the innate and adaptive immune system. The Company’s portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent of targeting the adenosine pathway. Within these six platforms, the Company has 14 products in development with multiple clinical readouts.

NDAQ:PRTG - Post by User

Portage Biotech Inc

Bullboard Posts

Comment by pavelnedvedon Jul 09, 2015 9:55pm

121 Views

Post# 23909946

RE:Clear technical breakout ...

Well looks like the pump is over and this is destined to go back sub 10
once again and maybe in 2017 will be pumped again

go back in history, it's same pattern over and over.

Bullboard Posts

This gambling tech stock might be the safest bet you’ll make this year